14106 Federal Register / Vol. 89, No. 38 / Monday, February 26, 2024 / Notices 

(i) explain how the articles potentially 

subject to the recommended remedial 

orders are used in the United States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on March 

15, 2024. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 (Mar. 

19, 2020). Submissions should refer to 

the investigation number (‘‘Inv. No. 

337–TA–1341’’) in a prominent place on 

the cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

documents/handbook_on_filing_

procedures.pdf.). Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment by marking each document 

with a header indicating that the 

document contains confidential 

information. This marking will be 

deemed to satisfy the request procedure 

set forth in Rules 201.6(b) and 

210.5(e)(2) (19 CFR 201.6(b) & 

210.5(e)(2)). Documents for which 

confidential treatment by the 

Commission is properly sought will be 

treated accordingly. Any non-party 

wishing to submit comments containing 

confidential information must serve 

those comments on the parties to the 

investigation pursuant to the applicable 

Administrative Protective Order. A 

redacted non-confidential version of the 

document must also be filed 

simultaneously with any confidential 

filing and must be served in accordance 

with Commission Rule 210.4(f)(7)(ii)(A) 

(19 CFR 210.4(f)(7)(ii)(A)). All 

information, including confidential 

business information and documents for 

which confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in Part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: February 21, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–03825 Filed 2–23–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0003] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Automation of 

Reports and Consolidated Orders 

System (ARCOS) Transaction 

Reporting 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Drug Enforcement 

Administration, Department of Justice 

(DOJ), will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. This proposed 

information collection was previously 

published in the Federal Register on 

December 21, 2023, allowing for a 60- 

day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until March 

27, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 362–3261, email: 

DPW@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0003. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 38 / Monday, February 26, 2024 / Notices 14107 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. Title of the Form/Collection: 

ARCOS Transaction Reporting. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: DEA Form 333. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Private 

Sector—business or other for-profit 

institutions. 

Abstract: Section 307 of the 

Controlled Substances Act (21 U.S.C. 

827) requires controlled substance 

manufacturers and distributors to make 

periodic reports to DEA regarding the 

sale, delivery, and other disposal of 

certain controlled substances. These 

reports help ensure a closed system of 

distribution for controlled substances, 

and are used to comply with 

international treaty obligations. 

5. Obligation to Respond: Mandatory 

21 CFR 1304. 

6. Total Estimated Number of 

Respondents: 1,239. 

7. Estimated Time per Respondent: 

0.50 minutes for DEA Form 333 (paper) 

and 0.25 minutes for DEA Form 333 

(online) and DEA Form 333 (electronic 

data interchange). 

8. Frequency: 7.93866 per year. 

9. Total Estimated Annual Time 

Burden: 2,459 hours. 

10. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218 Washington, DC 20530. 

Dated: February 21, 2024. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2024–03806 Filed 2–23–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0021] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Dispensing 

Records of Individual Practitioners 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Drug Enforcement 

Administration, Department of Justice 

(DOJ), will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. This proposed 

information collection was previously 

published in the Federal Register on 

December 21, 2023, allowing for a 60- 

day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until March 

27, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 362–3261, email: 

DPW@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0021. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. Title of the Form/Collection: 

Dispensing Records of Individual 

Practitioners. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Form: N/A. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Private 

Sector—business or other for-profit. 

Abstract: Pursuant to 21 U.S.C. 827(c), 

practitioners who regularly dispense or 

administer controlled substances to 

patients and charge them for the 

substances and those practitioners who 

administer controlled substances in the 

course of maintenance or detoxification 

treatment shall keep records of such 

activities, and accordingly must comply 

with the regulations on recordkeeping. 

5. Obligation to Respond: Mandatory 

21 CFR 1317, 21 CFR 1307, 21 CFR 

1304. 

6. Total Estimated Number of 

Respondents: 72,333. 

7. Estimated Time per Respondent: 

0.5 minutes for dispensing records of 


khammond on DSKJM1Z7X2PROD with NOTICES